Advertisement
Desktop970x250
3News
Advertisement
Desktop970x250

No link between AstraZeneca vaccines and blood clot in Ghana yet – FDA

By Laud Nartey
SHARE
3 min read
No link between AstraZeneca vaccines and blood clot in Ghana yet – FDA

CEO of the FDA, Dr. Delese Darko

The Food and Drugs Authority (FDA) has said that there is currently no link between the AstraZeneca vaccine and blood clot yet in Ghana.

The FDA in a statement said the most commonly reported adverse events with the vaccines are headaches, fever, chills, body pains, pain at the injection site, weakness, nausea, and dizziness.

“These adverse events are expected from the vaccination and in most cases, resolved within a day or two. Additionally, the JCVSRC discussed reports of blood clots in some countries in Europe following vaccination with the AstraZeneca COVID-19 vaccine, leading to the suspension of vaccination for further investigations.

“It concluded that there is currently no causal link between the event and the vaccine, a position that was subsequently upheld by the European Medicines Agency and the World Health Organization.

“In view of the above, the FDA would like to reassure the public that it is closely monitoring this situation locally and to date, no events of blood clots linked to the Covishield vaccine have been reported among those who have been vaccinated in Ghana,” the statement said.

Below is the full statement by the FDA

On 26th February 2021, the Food and Drugs Authority constituted a Committee of Experts — the Joint COVID-19 Vaccine Safety Review Committee (JCVSRC) — which meets bi-weekly to assess all reported adverse events and make recommendations on the safety of COVID-19 vaccines.

At its meeting held on 12th March 2021, the JCVSRC discussed reports received through the FDA’s robust safety monitoring system since vaccinations started. The most commonly reported adverse events are headaches, fever, chills, body pains, pain at the injection site, weakness, nausea, and dizziness.

These adverse events are expected from the vaccination and in most cases, resolved within a day or two. Additionally, the JCVSRC discussed reports of blood clots in some countries in Europe following vaccination with the AstraZeneca COVID-19 vaccine, leading to the suspension of vaccination for further investigations.

It concluded that there is currently no causal link between the event and the vaccine, a position that was subsequently upheld by the European Medicines Agency and the World Health Organization.

In view of the above, the FDA would like to reassure the public that it is closely monitoring this situation locally and to date, no events of blood clots linked to the Covishield vaccine have been reported among those who have been vaccinated in Ghana.

Generally, vaccines and medicines tend to have some side effects and this needs to be continually balanced against the expected benefits in preventing illnesses.

The Authority continues to work with its Committee of Experts, other regulators globally and will use its established safety monitoring system to support the vaccine program to ensure public health and safety.

By Laud Nartey|editors.3news.com|Ghana

Sign up to The Daily Briefing

Stay informed with the most relevant stories shaping Ghana and the world, every morning and evening.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy.

Share This Article

Laud Nartey is an online editor with current affair team at Media General, operators of TV3 Ghana, 3News.com and more. Email: Laud.Nartey@editors.3news.com

Advertisement
Desktop300x250

Up Next

Advertisement
Desktop970x250